Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

105.68 -1.48 (-1.38%)
Streaming Delayed Price Updated: 10:22 AM EDT, Aug 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Lantheus Holdings

< Previous 1 2 3 Next >
Lantheus to Host Third Quarter 2022 Earnings Conference Call and Webcast on November 3, 2022, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Presentations at the European Association of Nuclear Medicine Annual Meeting Showcased Artificial Intelligence Data
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces the First and Only FDA Cleared AI-Enabled PSMA Digital Application, aPROMISE™, Strengthening Lantheus’ Leadership in Prostate Cancer
From Lantheus Holdings, Inc.
Via Business Wire
Lantheus Holdings, Inc. Reports Second Quarter 2021 Financial Results
From Lantheus Holdings, Inc.
Via Business Wire
Lantheus Holdings to Host Second Quarter 2021 Earnings Conference Call and Webcast on July 28, 2021 at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via Business Wire
Lantheus To Present Piflufolastat F 18 Data at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting
From Lantheus Holdings, Inc.
Via Business Wire
Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer
From Lantheus Holdings, Inc.
Via Business Wire
Lantheus Holdings Announces Presentation Featuring 18F-DCFPyL PET/CT, its PSMA-Targeted Prostate Cancer Imaging Agent at the 2021 ASCO Annual Meeting
From Lantheus Holdings, Inc.
Via Business Wire
Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference
From Lantheus Holdings, Inc.
Via Business Wire
Lantheus Holdings, Inc. Reports First Quarter 2021 Financial Results
From Lantheus Holdings, Inc.
Via Business Wire
EXINI Diagnostics AB, a Lantheus Company, Receives CE Mark Clearance for aPROMISE in Europe
From Lantheus Holdings, Inc.
Via Business Wire
Lantheus Grants Allegheny Health Network Exclusive Rights for the Use of its Microbubbles in Combination with Ultrasound Assisted Gene Therapy for the Development of a Proposed Treatment for Xerostomia
From Lantheus Holdings, Inc.
Via Business Wire
Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via Business Wire
Lantheus Expands R&D Leadership Team with Key New Hires
From Lantheus Holdings, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.